Cargando…
Bullous Pemphigoid: Trigger and Predisposing Factors
Bullous pemphigoid (BP) is the most frequent autoimmune subepidermal blistering disease provoked by autoantibodies directed against two hemidesmosomal proteins: BP180 and BP230. Its pathogenesis depends on the interaction between predisposing factors, such as human leukocyte antigen (HLA) genes, com...
Autores principales: | Moro, Francesco, Fania, Luca, Sinagra, Jo Linda Maria, Salemme, Adele, Di Zenzo, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600534/ https://www.ncbi.nlm.nih.gov/pubmed/33050407 http://dx.doi.org/10.3390/biom10101432 |
Ejemplares similares
-
Case report: Bullous pemphigoid arising in a patient with scleroderma and multiple sclerosis
por: Moro, Francesco, et al.
Publicado: (2022) -
Autoimmune bullous diseases during COVID-19 pandemic: 2022 update on rituximab and vaccine
por: Pira, Anna, et al.
Publicado: (2023) -
Bullous pemphigoid in diabetic patients treated by gliptins: the other side of the coin
por: Chouchane, Karim, et al.
Publicado: (2021) -
Pilot study investigating BP-180 in extracellular vesicles derived from blister fluid of bullous pemphigoid patients
por: Gasparini, Giulia, et al.
Publicado: (2023) -
New Insights Into the Pathogenesis of Bullous Pemphigoid: 2019 Update
por: Genovese, Giovanni, et al.
Publicado: (2019)